Figures & data
Figure 1. Patient disposition. Abbreviations. AC, anticoagulant; AF, atrial fibrillation; VTE, venous thromboembolism. 1Cancer treatment included non-radiation and radiation therapies. 2Defined as a procedure code for major surgery, abdominopelvic surgery, and neurosurgery or orthopedic surgery during an inpatient stay.
![Figure 1. Patient disposition. Abbreviations. AC, anticoagulant; AF, atrial fibrillation; VTE, venous thromboembolism. 1Cancer treatment included non-radiation and radiation therapies. 2Defined as a procedure code for major surgery, abdominopelvic surgery, and neurosurgery or orthopedic surgery during an inpatient stay.](/cms/asset/7255b5af-8c75-40c4-8276-54e17dfe5ebc/ijme_a_1948681_f0001_b.jpg)
Table 1. Demographic and clinical characteristics.
Figure 2. All-cause total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).
![Figure 2. All-cause total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).](/cms/asset/9283db9d-e767-41f3-bacc-1ddb2fb29874/ijme_a_1948681_f0002_c.jpg)
Table 2. Healthcare costs per patient per month up to 12 months of follow-up.
Figure 3. VTE-related total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score; VTE, venous thromboembolism. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).
![Figure 3. VTE-related total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score; VTE, venous thromboembolism. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).](/cms/asset/c869ac4c-6225-47f9-a303-95a8c1d954ee/ijme_a_1948681_f0003_c.jpg)